Quantum Genomics' Unattributed - II Round

Quantum Genomics raised a round of funding on July 28, 2017.

Quantum Genomics is a biopharmaceutical company dedicated to developing new therapies for unmet medical needs in the field of cardiovascular diseases, including hypertension and heart failure.…

Articles about Quantum Genomics' Unattributed - II Round: